A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
A phase 2 trial of Midostaurin, Fludarabine, Cytarabine, Daunorubicin, Idarubicin and Mitoxantrone in acute myeloid leukaemia, run by Novartis Pharmaceuticals, active and no longer recruiting.
Overview
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML is a phase 2 interventional study registered as NCT03591510 by Novartis Pharmaceuticals, with 22 participants enrolled, started 2019-03-13 and due to reach its primary completion in 2029-05-18. Interventions recorded: Midostaurin, Fludarabine, Cytarabine, Daunorubicin or idarubicin, Mitoxantrone and Etoposide.
Similar pages
not linked directly; found by shared links- TrialA Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation
Shares Mitoxantrone, Cytarabine, Fludarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialA Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
Shares Daunorubicin, Cytarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialStudies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Shares Daunorubicin, Cytarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialSafety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
Shares Cytarabine, Fludarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialSafety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
Shares Cytarabine, Advanced Accelerator Applications (Novartis) and the tag pipeline.
- TrialGalinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
Shares Cytarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialClinical Study of Mitoxantrone Hydrochloride Liposome Injection vs. Chidamide in Patients With Relapsed/Refractory PTCL
Shares Mitoxantrone and the tag pipeline.
- TrialClinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
Shares Fludarabine, Acute myeloid leukaemia and the tag pipeline.